Forecasts data is unavailable for this security.
Consensus recommendation
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Mira Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 17.75 and a low estimate of 7.50. The median estimate represents a 773.02% increase from the last price of 1.26.
High | 1,308.7% | 17.75 |
Med | 773.0% | 11.00 |
Low | 495.2% | 7.50 |
Earnings history & estimates in USD
Average growth rate | +11.64% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼